pharma · Amyotrophic Lateral Sclerosis · Acute Myeloid Leukemia
AB Science
AB Science is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Amyotrophic Lateral Sclerosis, Acute Myeloid Leukemia, Mastocytosis, Mast cell activation syndrome, Multiple Scleros
PARIS, FR HQ
20 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- PARIS, FR
- Employees
- 20
- Programs
- 6
- Drugs
- 11
- Patents
- 25
AB18001
Phase 2 · small molecule · Acute Myeloid Leukemia
AB18001 for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Internal code AB18001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AB Science
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Acute Myeloid Leukemia
- Status
- active
- Trials
- 1